Related content

Mechanisms of action of mifepristone when used for emergency contraception

By Gemzell-Danielsson K.   Mandl I.   Marions L.  

Contraception, Vol. 68, Iss. 6, 2003-12 ,pp. : 471-476

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of 10 mg of mifepristone

By Leminen R.   Ranta S.   von Hertzen H.   Oehler J.   Heikinheimo O.  

Contraception, Vol. 68, Iss. 6, 2003-12 ,pp. : 427-429

Elsevier

Access to resources Recommend Favorite

Mifepristone: bioavailability, pharmacokinetics and use-effectiveness

By Sarkar N.N.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 101, Iss. 2, 2002-03 ,pp. : 113-120

Elsevier

Access to resources Recommend Favorite

Cervical ripening after treatment with prostaglandin E 2 or antiprogestin (RU486). Possible mechanisms in relation to gonadal steroids

By Stjernholm Y.M.   Sahlin L.   Eriksson H.A.   Bystrom B.E.   Stenlund P.-M.   Ekman G.E.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 84, Iss. 1, 1999-05 ,pp. : 83-88

Elsevier

Access to resources Recommend Favorite

A multiparametric study of the action of mifepristone used in emergency contraception using the Rhesus monkey as a primate model

By Sengupta J.   Dhawan L.   Lalitkumar P.G.L.   Ghosh D.  

Contraception, Vol. 68, Iss. 6, 2003-12 ,pp. : 453-469

Elsevier

Access to resources Recommend Favorite